Bernard Coulie and Kevin Marks bring significant corporate, drug development, and compliance experience to the CMTA BoardThe CMTA Board and…
Data highlights the incidence of abuse and accidental pediatric exposure of transdermal patches containing opioid and stimulant drugsNutriband's AVERSA™ technology…
STOCKHOLM, SWEDEN / ACCESSWIRE / March 25, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) A leading 1,100-bed hospital in Bavaria commences…
TORONTO, ON / ACCESSWIRE / March 25, 2024 / ProteinQure, the leading startup in the computational design of peptide drugs,…
JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the…
HAMILTON, BERMUDA, March 25, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira’s SemaPhore™ nanoparticlesTargeting safer…
Non-dilutive funding strengthens balance sheet and extends current operating runway LAWRENCEVILLE, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc.…
Data demonstrates that Company’s Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor responses New data shows…
NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and olderMALVERN, Pa.,…
- Landos’ lead asset, NX-13, is a first-in-class, oral NLRX1 agonist in Phase 2 for the treatment of ulcerative colitis…